UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in AMGN — Amgen Inc
CIK 861177
NEW YORK, NY
Position in AMGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,683,595,911
+$176,654,458 QoQ
Shares Held
4,784,982
+3.9% QoQ
Ownership
0.887%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 56.12888407939675.ToString("F0")%
Shared 0.ToString("F0")%
None 43.87111592060325.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $23,080,171,805 across 16 Drug Manufacturers - General names. AMGN ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,072,021 | $6,504,632,749 | |
| 2 | JNJ |
Johnson & Johnson
|
19,628,113 | $4,797,895,938 | |
| 3 | ABBV |
AbbVie Inc.
|
14,161,606 | $3,080,007,683 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,414,819 | $2,455,698,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,199,103 | $1,839,558,979 | |
| 6 | AMGN |
Amgen Inc
This page
|
4,784,982 | $1,683,595,911 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
22,719,320 | $1,377,926,752 | |
| 8 | PFE |
Pfizer Inc
|
34,522,932 | $969,403,925 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,683,595,911 | 4,784,982 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,506,941,453 | 4,604,019 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,283,811,891 | 4,549,298 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,474,909,784 | 5,282,439 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,449,437,144 | 4,652,342 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,336,647,403 | 5,128,328 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,431,431,772 | 4,442,543 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,305,462,023 | 4,178,147 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $957,172,942 | 3,366,534 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,042,964,481 | 3,621,153 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $888,426,487 | 3,305,650 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $734,536,514 | 3,308,425 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $799,811,739 | 3,308,425 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $759,441,115 | 3,369,304 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $850,819,363 | 3,496,997 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $912,056,044 | 3,771,632 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $810,823,819 | 3,604,142 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $739,969,469 | 3,479,753 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $840,609,165 | 3,448,653 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $848,212,940 | 3,409,079 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $786,018,074 | 3,418,659 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $850,742,900 | 3,347,273 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $807,624,259 | 3,424,168 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $612,435,163 | 3,020,940 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||